Len Pattenden
About Len Pattenden
Len Pattenden serves as the Vector Upstream Development Group Leader II at Adaptimmune US, a position he has held since 2018. He has a background in research and development, having previously worked at Lonza and held postdoctoral roles at Monash University and RMIT University.
Work at Adaptimmune
Len Pattenden has been employed at Adaptimmune US since 2018, serving as the Vector Upstream Development Group Leader II. In this role, he is responsible for overseeing the development of vector upstream processes, contributing to the advancement of the company's therapeutic programs. His tenure at Adaptimmune has extended for six years, during which he has played a key role in the organization's research and development efforts.
Previous Experience at Lonza
Prior to his current position, Len Pattenden worked at Lonza as a Senior Group Leader in Research and Development for a brief period in 2018. His role involved leading initiatives within the R&D department, although his time there lasted only five months.
Academic Background and Education
Len Pattenden pursued his education at the Queensland University of Technology (QUT), where he studied at the Faculty of Education. He achieved a Doctor of Philosophy degree, completing his studies from 1997 to 2004 over a span of seven years.
Research Roles at Monash and RMIT Universities
Len Pattenden has held significant research positions at prominent institutions. He served as a Senior Postdoctoral Fellow at Monash University from 2005 to 2009 for four years, followed by a similar role at RMIT University from 2009 to 2011 for two years. These positions contributed to his expertise in research and development within the academic sector.